Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice
Drug Delivery and Translational Research · 2025
DOI: 10.1007/s13346-024-01570-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Yanan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China. Hauptthemen laut MEDLINE: Imatinib Mesylate, Burns, Chemical, Eye Burns. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Imatinib (IMB) is a type of tyrosine kinase inhibitor with great application potential for inhibiting corneal neovascularization (CNV), but its poor water solubility limits its application in eye disease treatment. In this study, novel IMB@glycymicelles entrapped in hydrogel (called IMB@glycymicelle-hydrogel) were prepared, characterized, and evaluated for their therapeutic effects on corneal alkali burn in mice. Imatinib could be successfully loaded in glycymicelles using glycyrrhizin as a nanocarrier with an optimized weight ratio of IMB:nanocarrier. The apparent solubility of IMB was significantly improved from 61.69 ± 5.55 μg/mL to bare IMB to 359,967.62 ± 20,059.42 μg/mL to IMB@glycymicelles. Then, the IMB@glycymicelles were entrapped in hydrogel fabricated with hydroxypropyl methylcellulose and sodium hyaluronate (HA) to prolong retention time on the ocular surface. Rabbit eye tolerance tests showed that IMB@glycymicelle-hydrogel possessed good ocular safety profiles. In a mouse model of corneal alkali burns, the topical administration of IMB@glycymicelle-hydrogel showed strong efficacy by prompting corneal wound healing, recovering corneal sensitivity, relieving corneal opacities, and inhibiting CNV, and these efficacy evaluation parameters were better than those of the positive drug HA. Overall, these results demonstrated that IMB@glycymicelle-hydrogel may be a promising candidate for the effective treatment of alkali ocular damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China.
- Deparment of Pathology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
- Qingdao Women and Children's Hospital, Qingdao, China.
- Viwit Pharmaceutical Co., Ltd. Zaozhuang, Shandong, China.
- College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China. wuxianggen@126.com.
- Viwit Pharmaceutical Co., Ltd. Zaozhuang, Shandong, China. wuxianggen@126.com.
ORCID-Profile: Xianggen Wu
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, Y., Shi, S., Zhang, L., Wang, S., Qin, H., Wei, Y., Wu, X., & Zhang, M. (2025). Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01570-5
Vancouver
Wang Y, Shi S, Zhang L, Wang S, Qin H, Wei Y, et al. Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01570-5
BibTeX
@article{Wang2025,
author = {Wang, Yanan and Shi, Shaohua and Zhang, Ling and Wang, Songtao and Qin, Hongqing and Wei, Yanjun and Wu, Xianggen and Zhang, Mengmeng},
title = {Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice},
journal = {Drug Delivery and Translational Research},
year = {2025},
doi = {10.1007/s13346-024-01570-5}
}
EUVIMED